The Form 4 filing, an SEC report of an insider's stock activity, was filed on October 27, 2026. It gives October 23, 2026, as the purchase date for Barnes Michael Gene, who serves as Tiptree's chairman and CEO.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-23 |
| Date of Latest Transaction | 2026-10-23 |
| Buy/Sell | buy |
| Transaction Count | 1 |
| Shares Transacted | 30,930 |
| Price | $16.24 |
| Total Transaction Value | $502,303.20 |
| Insider | |
| Ticker Symbol | TIPT |
| Company | TIPTREE INC. |
| Insider Name | Barnes Michael Gene |
| Insider Title | Chairman and CEO |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 10,116,358 |
| Position Size Change | 0.31% |
| Filing | |
| Filing Date | 2026-10-27 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a stock purchase, recorded with transaction code P. Barnes Michael Gene bought shares of Tiptree (TIPT) in one reported transaction on October 23, 2026.
What was the average price of the transaction?
The average price was $16.24 per share. This is the reported average for the 30,930 shares bought in that transaction.
How did this transaction affect the insider's holdings?
The purchase added 30,930 shares. The reported number owned after the trade was 10,116,358 shares. The newly bought shares made up about 0.31% of that reported balance.
What's the total transaction value?
The total reported transaction value was $502,303.20. That amount covers the single purchase of 30,930 shares.
Are there any special circumstances around this transaction?
The transaction information includes a Rule 10b5-1 plan reference. These plans set trading instructions in advance. The available details do not confirm which trades the reference covers.
No footnote text was provided to show whether the reference applies to this purchase or the filing as a whole. The date the plan was set up and its trading schedule are unknown.
For research purposes only; not investment advice.